🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is a Phase 3, double-blind, placebo-controlled, randomized withdr...
Status
Recruiting
Location
Clinical Research Site
Start Date
2026-01-14
Trial ID
NCT07398417
Treatments Being Tested
This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the ...
Status
Enrolling By Invitation
Location
Clinical Research Site
Start Date
2026-04-29
Trial ID
NCT07637162
Treatments Being Tested
This Phase 1 study will assess the effects of esreboxetine on the heart. In...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-12
Trial ID
NCT00809289
Treatments Being Tested
The study is designed to assess if esreboxetine can improve the cognitive f...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-08
Trial ID
NCT00752505
Treatments Being Tested
The hypothesis of Study A6061054 is to demonstrate superiority of efficacy ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-05-01
Trial ID
NCT00796601
Treatments Being Tested
The purpose of the study is to learn more about how esreboxetine is handled...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00800956
Treatments Being Tested